Free Trial

Xponance Inc. Sells 4,006 Shares of Xylem Inc. (NYSE:XYL)

Xylem logo with Industrial Products background

Xponance Inc. lowered its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 10.5% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 33,970 shares of the industrial products company's stock after selling 4,006 shares during the quarter. Xponance Inc.'s holdings in Xylem were worth $4,607,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in XYL. D.A. Davidson & CO. increased its stake in shares of Xylem by 23.1% in the fourth quarter. D.A. Davidson & CO. now owns 8,655 shares of the industrial products company's stock valued at $990,000 after purchasing an additional 1,625 shares during the period. Commerce Bank increased its position in Xylem by 13.7% in the 4th quarter. Commerce Bank now owns 10,878 shares of the industrial products company's stock valued at $1,244,000 after acquiring an additional 1,313 shares during the period. SageView Advisory Group LLC bought a new stake in Xylem during the 4th quarter valued at $304,000. Nomura Asset Management Co. Ltd. boosted its position in Xylem by 1.5% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 81,754 shares of the industrial products company's stock worth $9,349,000 after acquiring an additional 1,184 shares during the period. Finally, Hsbc Holdings PLC grew its stake in shares of Xylem by 5.9% in the fourth quarter. Hsbc Holdings PLC now owns 812,551 shares of the industrial products company's stock worth $92,951,000 after purchasing an additional 45,163 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

Xylem Stock Down 1.1 %

NYSE:XYL opened at $133.06 on Wednesday. Xylem Inc. has a 1-year low of $87.59 and a 1-year high of $146.08. The firm has a market capitalization of $32.32 billion, a price-to-earnings ratio of 47.35, a PEG ratio of 2.37 and a beta of 1.04. The company has a current ratio of 1.85, a quick ratio of 1.33 and a debt-to-equity ratio of 0.19. The business's fifty day moving average price is $133.46 and its 200 day moving average price is $134.34.

Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings results on Tuesday, July 30th. The industrial products company reported $1.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.05 by $0.04. Xylem had a net margin of 9.11% and a return on equity of 9.48%. The business had revenue of $2.17 billion during the quarter, compared to analyst estimates of $2.14 billion. During the same period in the prior year, the firm earned $0.98 earnings per share. The firm's revenue was up 26.0% compared to the same quarter last year. On average, sell-side analysts forecast that Xylem Inc. will post 4.26 earnings per share for the current fiscal year.

Xylem Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 26th. Stockholders of record on Thursday, August 29th will be issued a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 1.08%. The ex-dividend date of this dividend is Thursday, August 29th. Xylem's dividend payout ratio is currently 51.25%.

Analysts Set New Price Targets

XYL has been the subject of several research analyst reports. Stifel Nicolaus upped their price objective on shares of Xylem from $170.00 to $172.00 and gave the stock a "buy" rating in a report on Wednesday, July 31st. TD Cowen restated a "hold" rating and issued a $138.00 target price on shares of Xylem in a research report on Tuesday, September 3rd. Oppenheimer boosted their price objective on Xylem from $147.00 to $152.00 and gave the stock an "outperform" rating in a research note on Friday, May 31st. Robert W. Baird raised their target price on Xylem from $155.00 to $170.00 and gave the company an "outperform" rating in a research note on Wednesday, July 31st. Finally, Argus boosted their price target on shares of Xylem from $146.00 to $165.00 and gave the stock a "buy" rating in a research report on Wednesday, May 29th. Five investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $147.54.

Get Our Latest Analysis on Xylem

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Further Reading

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

→ US Government to issue new currency ? (From Stansberry Research) (Ad)

Should you invest $1,000 in Xylem right now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Nvidia Tops Congressional Buy List
Top 3 Stocks Members of Congress are Buying Ahead of the Election
Fed Walking a Tightrope with Rate Cuts

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines